Sessions

Session Date
Overcoming Prostate Cancer Resistance through Inhibition of Translesion DNA Synthesis & Repurposing beta-blockers to license immunotherapy in brain tumors 07/19/2023 - 8:00am to 9:00am EDT
National Chemotherapy Shortages and the Impact on Oncologic Care in North Carolina / Thoughts for a New Academic Year: Burnout, Grief, & Education 07/26/2023 - 8:00am to 9:00am EDT
Investigating the non-canonical role of Hippo Kinase, serine/threonine kinase 3 (STK3) in prostate cancer / Investigating the Impact of ABL Kinase Signaling on Epigenetic Reprogramming in Metastatic Triple Negative Breast Cancer 08/02/2023 - 8:00am to 9:00am EDT
The role of estrogens in modulating natural killer cells in breast cancer metastasis / A Research Update on Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors 08/09/2023 - 8:00am to 9:00am EDT
Enhancing natural killer cell cytotoxicity by targeting HLA-E / AIMing for a Novel B Cell Checkpoint in cGVHD and Lymphoma 08/16/2023 - 8:00am to 9:00am EDT
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 08/23/2023 - 8:00am to 9:00am EDT
Targeting HER2 in Metastatic Colorectal Cancer: The Current Landscape and Mechanisms of Resistance & Fertility Preservation and Pregnancy in Young Women with Breast Cancer 08/30/2023 - 8:00am to 9:00am EDT
Hematology Division Updates 09/06/2023 - 8:00am to 9:00am EDT
Division of Hematologic Malignancies & Cellular Therapy Updates Part 1 09/13/2023 - 8:00am to 9:00am EDT
Division of Hematologic Malignancies & Cellular Therapy Updates Part 2 09/20/2023 - 8:00am to 9:00am EDT

Pages